| 17.2 |
68.9 |
GO:2001032 |
regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
| 13.1 |
39.4 |
GO:0032877 |
positive regulation of DNA endoreduplication(GO:0032877) |
| 10.6 |
52.9 |
GO:0007089 |
traversing start control point of mitotic cell cycle(GO:0007089) |
| 9.4 |
28.2 |
GO:0072138 |
mesenchymal cell proliferation involved in ureteric bud development(GO:0072138) |
| 7.7 |
23.1 |
GO:0072050 |
comma-shaped body morphogenesis(GO:0072049) S-shaped body morphogenesis(GO:0072050) |
| 7.0 |
34.9 |
GO:1903553 |
positive regulation of extracellular exosome assembly(GO:1903553) |
| 6.6 |
26.6 |
GO:0070829 |
heterochromatin maintenance(GO:0070829) |
| 6.6 |
65.8 |
GO:0060272 |
embryonic skeletal joint morphogenesis(GO:0060272) |
| 6.4 |
19.1 |
GO:0007354 |
zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
| 6.3 |
31.6 |
GO:0046601 |
positive regulation of centriole replication(GO:0046601) |
| 5.7 |
45.6 |
GO:0033314 |
mitotic DNA replication checkpoint(GO:0033314) |
| 5.5 |
82.7 |
GO:0010216 |
maintenance of DNA methylation(GO:0010216) |
| 5.4 |
21.6 |
GO:0018242 |
protein O-linked glycosylation via serine(GO:0018242) |
| 5.3 |
168.2 |
GO:0006270 |
DNA replication initiation(GO:0006270) |
| 5.2 |
15.7 |
GO:0061144 |
alveolar secondary septum development(GO:0061144) |
| 5.2 |
15.6 |
GO:1901420 |
negative regulation of response to alcohol(GO:1901420) |
| 5.1 |
15.3 |
GO:0006189 |
'de novo' IMP biosynthetic process(GO:0006189) |
| 4.6 |
9.2 |
GO:0007418 |
ventral midline development(GO:0007418) |
| 4.6 |
23.0 |
GO:0046654 |
tetrahydrofolate biosynthetic process(GO:0046654) |
| 4.6 |
13.7 |
GO:0040009 |
regulation of growth rate(GO:0040009) |
| 4.6 |
22.8 |
GO:0015705 |
iodide transport(GO:0015705) |
| 4.4 |
22.0 |
GO:0045578 |
negative regulation of B cell differentiation(GO:0045578) |
| 4.4 |
17.6 |
GO:0046607 |
positive regulation of centrosome cycle(GO:0046607) |
| 4.3 |
12.9 |
GO:0070315 |
G1 to G0 transition involved in cell differentiation(GO:0070315) |
| 4.3 |
12.8 |
GO:0097402 |
neuroblast migration(GO:0097402) |
| 4.2 |
8.4 |
GO:0045014 |
carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
| 4.2 |
29.4 |
GO:0033567 |
DNA replication, Okazaki fragment processing(GO:0033567) |
| 4.2 |
12.6 |
GO:0006348 |
chromatin silencing at telomere(GO:0006348) |
| 4.1 |
12.4 |
GO:0060718 |
chorionic trophoblast cell differentiation(GO:0060718) |
| 4.1 |
12.4 |
GO:0006166 |
purine ribonucleoside salvage(GO:0006166) |
| 4.0 |
4.0 |
GO:0030997 |
regulation of centriole-centriole cohesion(GO:0030997) |
| 3.9 |
31.1 |
GO:0033504 |
floor plate development(GO:0033504) |
| 3.9 |
3.9 |
GO:0061047 |
positive regulation of branching involved in lung morphogenesis(GO:0061047) |
| 3.8 |
11.5 |
GO:0006269 |
DNA replication, synthesis of RNA primer(GO:0006269) |
| 3.8 |
61.3 |
GO:0009263 |
deoxyribonucleotide biosynthetic process(GO:0009263) |
| 3.8 |
11.4 |
GO:2000768 |
glomerular parietal epithelial cell differentiation(GO:0072139) positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) positive regulation of nephron tubule epithelial cell differentiation(GO:2000768) |
| 3.6 |
14.5 |
GO:0048304 |
positive regulation of isotype switching to IgG isotypes(GO:0048304) |
| 3.6 |
14.3 |
GO:0051311 |
spindle assembly involved in female meiosis(GO:0007056) meiotic metaphase plate congression(GO:0051311) |
| 3.5 |
10.6 |
GO:0003221 |
right ventricular cardiac muscle tissue morphogenesis(GO:0003221) ventricular compact myocardium morphogenesis(GO:0003223) |
| 3.4 |
44.8 |
GO:0007076 |
mitotic chromosome condensation(GO:0007076) |
| 3.4 |
10.3 |
GO:0032474 |
otolith morphogenesis(GO:0032474) |
| 3.4 |
13.8 |
GO:0006203 |
dGTP catabolic process(GO:0006203) dATP catabolic process(GO:0046061) |
| 3.4 |
10.2 |
GO:0030167 |
proteoglycan catabolic process(GO:0030167) |
| 3.3 |
39.7 |
GO:0019985 |
translesion synthesis(GO:0019985) |
| 3.3 |
13.1 |
GO:0070318 |
positive regulation of G0 to G1 transition(GO:0070318) |
| 3.3 |
9.8 |
GO:1904395 |
regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904393) positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
| 3.2 |
9.7 |
GO:0021759 |
globus pallidus development(GO:0021759) |
| 3.2 |
25.4 |
GO:1900262 |
regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 3.1 |
3.1 |
GO:1902861 |
copper ion import into cell(GO:1902861) |
| 3.1 |
28.0 |
GO:0060613 |
fat pad development(GO:0060613) |
| 3.1 |
18.6 |
GO:0098535 |
de novo centriole assembly(GO:0098535) |
| 3.1 |
9.3 |
GO:2000620 |
positive regulation of histone H4-K16 acetylation(GO:2000620) |
| 3.0 |
9.1 |
GO:1900158 |
negative regulation of bone mineralization involved in bone maturation(GO:1900158) |
| 3.0 |
11.9 |
GO:2000774 |
positive regulation of cellular senescence(GO:2000774) |
| 3.0 |
8.9 |
GO:0000710 |
meiotic mismatch repair(GO:0000710) |
| 2.9 |
14.5 |
GO:0046602 |
regulation of mitotic centrosome separation(GO:0046602) |
| 2.9 |
8.6 |
GO:0046060 |
dATP metabolic process(GO:0046060) |
| 2.8 |
14.2 |
GO:0030091 |
protein repair(GO:0030091) |
| 2.8 |
5.5 |
GO:0021937 |
cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
| 2.7 |
32.9 |
GO:2000381 |
negative regulation of mesoderm development(GO:2000381) |
| 2.7 |
8.2 |
GO:0042732 |
D-xylose metabolic process(GO:0042732) |
| 2.7 |
8.1 |
GO:0060598 |
dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis(GO:0060598) |
| 2.7 |
13.5 |
GO:0072383 |
plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
| 2.7 |
10.7 |
GO:0006526 |
'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) arginine biosynthetic process(GO:0006526) pyrimidine nucleobase biosynthetic process(GO:0019856) |
| 2.7 |
8.0 |
GO:0002184 |
cytoplasmic translational termination(GO:0002184) |
| 2.7 |
8.0 |
GO:0072757 |
cellular response to camptothecin(GO:0072757) |
| 2.6 |
10.6 |
GO:0035878 |
nail development(GO:0035878) |
| 2.6 |
10.5 |
GO:0051315 |
attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
| 2.6 |
10.3 |
GO:0044861 |
protein transport into plasma membrane raft(GO:0044861) |
| 2.5 |
32.9 |
GO:0034501 |
protein localization to kinetochore(GO:0034501) |
| 2.5 |
17.7 |
GO:0001842 |
neural fold formation(GO:0001842) |
| 2.5 |
12.5 |
GO:0006543 |
glutamine catabolic process(GO:0006543) |
| 2.4 |
12.0 |
GO:0021905 |
pancreatic A cell development(GO:0003322) forebrain-midbrain boundary formation(GO:0021905) somatic motor neuron fate commitment(GO:0021917) regulation of transcription from RNA polymerase II promoter involved in somatic motor neuron fate commitment(GO:0021918) |
| 2.4 |
9.6 |
GO:1903519 |
apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
| 2.3 |
11.7 |
GO:0071305 |
cellular response to vitamin D(GO:0071305) |
| 2.3 |
16.3 |
GO:0061087 |
positive regulation of histone H3-K27 methylation(GO:0061087) |
| 2.3 |
7.0 |
GO:0014826 |
vein smooth muscle contraction(GO:0014826) |
| 2.3 |
6.9 |
GO:0032240 |
negative regulation of nucleobase-containing compound transport(GO:0032240) negative regulation of RNA export from nucleus(GO:0046832) |
| 2.3 |
6.9 |
GO:2000686 |
regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
| 2.3 |
6.8 |
GO:0070634 |
transepithelial ammonium transport(GO:0070634) |
| 2.3 |
9.0 |
GO:0071139 |
resolution of recombination intermediates(GO:0071139) |
| 2.3 |
6.8 |
GO:2000418 |
positive regulation of eosinophil migration(GO:2000418) |
| 2.2 |
2.2 |
GO:1902263 |
apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
| 2.2 |
11.1 |
GO:0031860 |
telomeric 3' overhang formation(GO:0031860) |
| 2.2 |
8.9 |
GO:2001245 |
regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
| 2.2 |
8.9 |
GO:0035606 |
peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 2.2 |
8.7 |
GO:0035262 |
gonad morphogenesis(GO:0035262) |
| 2.2 |
8.7 |
GO:2001045 |
closure of optic fissure(GO:0061386) negative regulation of integrin-mediated signaling pathway(GO:2001045) |
| 2.1 |
6.4 |
GO:0034184 |
positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
| 2.1 |
8.4 |
GO:0036089 |
cleavage furrow formation(GO:0036089) |
| 2.1 |
6.3 |
GO:0000707 |
meiotic DNA recombinase assembly(GO:0000707) |
| 2.1 |
6.2 |
GO:0001978 |
regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback(GO:0001978) |
| 2.1 |
10.4 |
GO:0035331 |
negative regulation of hippo signaling(GO:0035331) |
| 2.1 |
10.3 |
GO:0070345 |
negative regulation of fat cell proliferation(GO:0070345) |
| 2.1 |
8.2 |
GO:0003360 |
brainstem development(GO:0003360) |
| 2.0 |
6.1 |
GO:0061300 |
cerebellum vasculature development(GO:0061300) |
| 2.0 |
12.0 |
GO:2000042 |
negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
| 2.0 |
6.0 |
GO:0061304 |
retinal blood vessel morphogenesis(GO:0061304) |
| 2.0 |
9.9 |
GO:2000348 |
regulation of CD40 signaling pathway(GO:2000348) |
| 2.0 |
9.9 |
GO:0071557 |
histone H3-K27 demethylation(GO:0071557) |
| 2.0 |
5.9 |
GO:0072675 |
osteoclast fusion(GO:0072675) |
| 2.0 |
5.9 |
GO:0019441 |
tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) kynurenine metabolic process(GO:0070189) |
| 1.9 |
5.8 |
GO:2000313 |
fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
| 1.9 |
5.7 |
GO:0048496 |
maintenance of organ identity(GO:0048496) |
| 1.9 |
1.9 |
GO:0009113 |
purine nucleobase biosynthetic process(GO:0009113) |
| 1.8 |
7.3 |
GO:0070425 |
negative regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070425) negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070433) |
| 1.8 |
30.8 |
GO:0007530 |
sex determination(GO:0007530) |
| 1.8 |
5.4 |
GO:0002408 |
myeloid dendritic cell chemotaxis(GO:0002408) |
| 1.8 |
3.6 |
GO:0009162 |
deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
| 1.8 |
14.3 |
GO:0016081 |
synaptic vesicle docking(GO:0016081) |
| 1.8 |
16.0 |
GO:0033327 |
Leydig cell differentiation(GO:0033327) |
| 1.7 |
26.0 |
GO:0043249 |
erythrocyte maturation(GO:0043249) |
| 1.7 |
10.3 |
GO:1900246 |
positive regulation of RIG-I signaling pathway(GO:1900246) |
| 1.7 |
8.6 |
GO:0006369 |
termination of RNA polymerase II transcription(GO:0006369) |
| 1.7 |
6.7 |
GO:1901492 |
positive regulation of lymphangiogenesis(GO:1901492) |
| 1.7 |
23.2 |
GO:0010569 |
regulation of double-strand break repair via homologous recombination(GO:0010569) |
| 1.7 |
8.3 |
GO:0072711 |
response to hydroxyurea(GO:0072710) cellular response to hydroxyurea(GO:0072711) |
| 1.6 |
1.6 |
GO:0007227 |
signal transduction downstream of smoothened(GO:0007227) |
| 1.6 |
11.4 |
GO:0006297 |
nucleotide-excision repair, DNA gap filling(GO:0006297) |
| 1.6 |
4.9 |
GO:0033860 |
regulation of NAD(P)H oxidase activity(GO:0033860) |
| 1.6 |
16.1 |
GO:0070940 |
dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 1.6 |
4.8 |
GO:0003349 |
epicardium-derived cardiac endothelial cell differentiation(GO:0003349) |
| 1.6 |
11.1 |
GO:0001675 |
acrosome assembly(GO:0001675) |
| 1.6 |
14.2 |
GO:0010457 |
centriole-centriole cohesion(GO:0010457) |
| 1.6 |
6.3 |
GO:0051305 |
chromosome movement towards spindle pole(GO:0051305) |
| 1.6 |
3.1 |
GO:0071224 |
cellular response to peptidoglycan(GO:0071224) |
| 1.6 |
6.2 |
GO:0072697 |
protein localization to cell cortex(GO:0072697) |
| 1.5 |
6.2 |
GO:0006741 |
NADP biosynthetic process(GO:0006741) |
| 1.5 |
10.8 |
GO:0051574 |
positive regulation of histone H3-K9 methylation(GO:0051574) |
| 1.5 |
4.5 |
GO:2000301 |
negative regulation of synaptic vesicle exocytosis(GO:2000301) |
| 1.5 |
22.7 |
GO:0031297 |
replication fork processing(GO:0031297) |
| 1.5 |
3.0 |
GO:0061743 |
motor learning(GO:0061743) |
| 1.5 |
3.0 |
GO:0001866 |
NK T cell proliferation(GO:0001866) |
| 1.5 |
4.5 |
GO:0051660 |
cortical microtubule organization(GO:0043622) establishment of centrosome localization(GO:0051660) |
| 1.5 |
4.4 |
GO:0036353 |
histone H2A-K119 monoubiquitination(GO:0036353) |
| 1.5 |
16.0 |
GO:0031936 |
negative regulation of chromatin silencing(GO:0031936) |
| 1.5 |
4.4 |
GO:0006931 |
substrate-dependent cell migration, cell attachment to substrate(GO:0006931) calcium-independent cell-matrix adhesion(GO:0007161) |
| 1.5 |
8.7 |
GO:2001269 |
positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
| 1.5 |
14.6 |
GO:0007064 |
mitotic sister chromatid cohesion(GO:0007064) |
| 1.4 |
4.3 |
GO:1902498 |
regulation of protein autoubiquitination(GO:1902498) |
| 1.4 |
24.3 |
GO:0030261 |
chromosome condensation(GO:0030261) |
| 1.4 |
8.5 |
GO:0002326 |
B cell lineage commitment(GO:0002326) |
| 1.4 |
4.3 |
GO:0051295 |
establishment of meiotic spindle localization(GO:0051295) |
| 1.4 |
14.1 |
GO:0036123 |
histone H3-K9 dimethylation(GO:0036123) |
| 1.4 |
1.4 |
GO:0043486 |
histone exchange(GO:0043486) |
| 1.4 |
2.7 |
GO:0090526 |
regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
| 1.3 |
5.4 |
GO:0002924 |
negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
| 1.3 |
13.2 |
GO:0051383 |
kinetochore assembly(GO:0051382) kinetochore organization(GO:0051383) |
| 1.3 |
5.2 |
GO:0010288 |
response to lead ion(GO:0010288) |
| 1.3 |
13.0 |
GO:0070574 |
cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
| 1.3 |
15.6 |
GO:0000244 |
spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 1.3 |
3.9 |
GO:0009446 |
putrescine biosynthetic process(GO:0009446) |
| 1.3 |
7.7 |
GO:0051461 |
regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
| 1.3 |
5.1 |
GO:0016266 |
O-glycan processing(GO:0016266) |
| 1.3 |
11.4 |
GO:0018095 |
protein polyglutamylation(GO:0018095) |
| 1.3 |
7.5 |
GO:0019336 |
phenol-containing compound catabolic process(GO:0019336) |
| 1.2 |
9.9 |
GO:0048617 |
embryonic foregut morphogenesis(GO:0048617) |
| 1.2 |
3.7 |
GO:0060800 |
regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
| 1.2 |
8.6 |
GO:0045198 |
establishment of epithelial cell apical/basal polarity(GO:0045198) |
| 1.2 |
2.5 |
GO:0072179 |
nephric duct formation(GO:0072179) |
| 1.2 |
3.7 |
GO:0033566 |
gamma-tubulin complex localization(GO:0033566) |
| 1.2 |
9.7 |
GO:0046599 |
regulation of centriole replication(GO:0046599) |
| 1.2 |
2.4 |
GO:0002842 |
T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) positive regulation of T cell mediated immune response to tumor cell(GO:0002842) |
| 1.2 |
3.6 |
GO:1904154 |
protein localization to endoplasmic reticulum exit site(GO:0070973) positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
| 1.2 |
3.6 |
GO:1902528 |
regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
| 1.2 |
2.4 |
GO:0060672 |
epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 1.2 |
3.6 |
GO:0090038 |
negative regulation of protein kinase C signaling(GO:0090038) |
| 1.1 |
26.1 |
GO:0045662 |
negative regulation of myoblast differentiation(GO:0045662) |
| 1.1 |
9.1 |
GO:0006398 |
mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 1.1 |
3.4 |
GO:0035526 |
retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 1.1 |
9.0 |
GO:0031053 |
primary miRNA processing(GO:0031053) |
| 1.1 |
10.0 |
GO:0072520 |
seminiferous tubule development(GO:0072520) |
| 1.1 |
4.3 |
GO:0045605 |
negative regulation of epidermal cell differentiation(GO:0045605) |
| 1.1 |
7.6 |
GO:0090209 |
negative regulation of triglyceride metabolic process(GO:0090209) |
| 1.1 |
4.3 |
GO:1902570 |
protein localization to nucleolus(GO:1902570) |
| 1.1 |
9.6 |
GO:0030903 |
notochord development(GO:0030903) |
| 1.1 |
4.2 |
GO:0043353 |
enucleate erythrocyte differentiation(GO:0043353) |
| 1.0 |
3.1 |
GO:1902396 |
protein localization to bicellular tight junction(GO:1902396) |
| 1.0 |
13.5 |
GO:0006353 |
DNA-templated transcription, termination(GO:0006353) |
| 1.0 |
6.2 |
GO:0002315 |
marginal zone B cell differentiation(GO:0002315) |
| 1.0 |
4.1 |
GO:0048631 |
regulation of skeletal muscle tissue growth(GO:0048631) |
| 1.0 |
9.2 |
GO:0043101 |
purine-containing compound salvage(GO:0043101) |
| 1.0 |
21.4 |
GO:0040034 |
regulation of development, heterochronic(GO:0040034) |
| 1.0 |
3.1 |
GO:1902894 |
negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
| 1.0 |
4.1 |
GO:1904690 |
regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
| 1.0 |
10.1 |
GO:0032682 |
negative regulation of chemokine production(GO:0032682) |
| 1.0 |
9.8 |
GO:0000183 |
chromatin silencing at rDNA(GO:0000183) |
| 1.0 |
9.6 |
GO:0043568 |
positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
| 1.0 |
6.7 |
GO:0002318 |
myeloid progenitor cell differentiation(GO:0002318) |
| 1.0 |
2.9 |
GO:0015772 |
disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 1.0 |
2.9 |
GO:0002331 |
pre-B cell allelic exclusion(GO:0002331) telomerase catalytic core complex assembly(GO:1904868) regulation of telomerase catalytic core complex assembly(GO:1904882) positive regulation of telomerase catalytic core complex assembly(GO:1904884) |
| 0.9 |
0.9 |
GO:0043974 |
histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
| 0.9 |
12.3 |
GO:0002087 |
regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
| 0.9 |
7.3 |
GO:0006004 |
fucose metabolic process(GO:0006004) |
| 0.9 |
8.2 |
GO:0033631 |
cell-cell adhesion mediated by integrin(GO:0033631) |
| 0.9 |
4.5 |
GO:0071896 |
protein localization to adherens junction(GO:0071896) |
| 0.9 |
9.0 |
GO:0000290 |
deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.9 |
2.7 |
GO:0006597 |
spermine biosynthetic process(GO:0006597) spermidine biosynthetic process(GO:0008295) |
| 0.9 |
4.5 |
GO:1902237 |
positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
| 0.9 |
1.8 |
GO:1900041 |
negative regulation of interleukin-2 secretion(GO:1900041) |
| 0.9 |
6.3 |
GO:0045925 |
positive regulation of female receptivity(GO:0045925) |
| 0.9 |
40.2 |
GO:0030514 |
negative regulation of BMP signaling pathway(GO:0030514) |
| 0.9 |
5.4 |
GO:0030916 |
otic vesicle formation(GO:0030916) |
| 0.9 |
4.4 |
GO:0018002 |
N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 0.9 |
23.5 |
GO:0045880 |
positive regulation of smoothened signaling pathway(GO:0045880) |
| 0.9 |
4.3 |
GO:0036337 |
Fas signaling pathway(GO:0036337) |
| 0.9 |
2.6 |
GO:0070889 |
platelet alpha granule organization(GO:0070889) |
| 0.9 |
6.0 |
GO:0090336 |
positive regulation of brown fat cell differentiation(GO:0090336) |
| 0.9 |
5.1 |
GO:2001020 |
regulation of response to DNA damage stimulus(GO:2001020) |
| 0.9 |
8.5 |
GO:0006610 |
ribosomal protein import into nucleus(GO:0006610) |
| 0.9 |
6.8 |
GO:0006817 |
phosphate ion transport(GO:0006817) |
| 0.9 |
4.3 |
GO:0001887 |
selenium compound metabolic process(GO:0001887) |
| 0.9 |
6.8 |
GO:2000653 |
regulation of genetic imprinting(GO:2000653) |
| 0.8 |
11.8 |
GO:0060052 |
neurofilament cytoskeleton organization(GO:0060052) |
| 0.8 |
2.5 |
GO:0006268 |
DNA unwinding involved in DNA replication(GO:0006268) |
| 0.8 |
7.5 |
GO:0034508 |
centromere complex assembly(GO:0034508) |
| 0.8 |
5.8 |
GO:0000103 |
sulfate assimilation(GO:0000103) |
| 0.8 |
5.8 |
GO:0097237 |
cellular response to toxic substance(GO:0097237) |
| 0.8 |
3.3 |
GO:0006167 |
AMP biosynthetic process(GO:0006167) |
| 0.8 |
1.6 |
GO:0032066 |
nucleolus to nucleoplasm transport(GO:0032066) |
| 0.8 |
2.4 |
GO:0051299 |
centrosome separation(GO:0051299) |
| 0.8 |
3.2 |
GO:0070278 |
extracellular matrix constituent secretion(GO:0070278) |
| 0.8 |
0.8 |
GO:0060528 |
secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
| 0.8 |
2.4 |
GO:1903416 |
response to glycoside(GO:1903416) |
| 0.8 |
13.3 |
GO:0016188 |
synaptic vesicle maturation(GO:0016188) |
| 0.8 |
6.2 |
GO:0000083 |
regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
| 0.8 |
3.1 |
GO:1903288 |
regulation of potassium ion import(GO:1903286) positive regulation of potassium ion import(GO:1903288) |
| 0.8 |
2.3 |
GO:0060161 |
positive regulation of dopamine receptor signaling pathway(GO:0060161) |
| 0.8 |
2.3 |
GO:0070213 |
protein auto-ADP-ribosylation(GO:0070213) |
| 0.7 |
3.7 |
GO:0015788 |
UDP-N-acetylglucosamine transport(GO:0015788) |
| 0.7 |
6.7 |
GO:0060746 |
parental behavior(GO:0060746) |
| 0.7 |
1.5 |
GO:0071603 |
endothelial cell-cell adhesion(GO:0071603) |
| 0.7 |
14.8 |
GO:0042753 |
positive regulation of circadian rhythm(GO:0042753) |
| 0.7 |
2.9 |
GO:0009414 |
response to water deprivation(GO:0009414) |
| 0.7 |
7.2 |
GO:0016127 |
cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.7 |
1.4 |
GO:0036075 |
endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
| 0.7 |
3.6 |
GO:0006072 |
glycerol-3-phosphate metabolic process(GO:0006072) |
| 0.7 |
7.1 |
GO:0038166 |
angiotensin-activated signaling pathway(GO:0038166) |
| 0.7 |
12.0 |
GO:0006613 |
cotranslational protein targeting to membrane(GO:0006613) |
| 0.7 |
4.2 |
GO:0060510 |
Type II pneumocyte differentiation(GO:0060510) |
| 0.7 |
4.2 |
GO:0098700 |
aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
| 0.7 |
6.2 |
GO:0071157 |
negative regulation of cell cycle arrest(GO:0071157) |
| 0.7 |
11.0 |
GO:2000001 |
regulation of DNA damage checkpoint(GO:2000001) |
| 0.7 |
6.2 |
GO:0075522 |
IRES-dependent viral translational initiation(GO:0075522) |
| 0.7 |
7.5 |
GO:0043011 |
myeloid dendritic cell differentiation(GO:0043011) |
| 0.7 |
4.1 |
GO:0035562 |
negative regulation of chromatin binding(GO:0035562) |
| 0.7 |
9.4 |
GO:0050774 |
negative regulation of dendrite morphogenesis(GO:0050774) |
| 0.7 |
6.7 |
GO:0007175 |
negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 0.7 |
8.1 |
GO:0048096 |
chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.7 |
1.3 |
GO:0046655 |
folic acid metabolic process(GO:0046655) |
| 0.7 |
3.3 |
GO:0035372 |
protein localization to microtubule(GO:0035372) |
| 0.7 |
3.3 |
GO:0010793 |
regulation of mRNA export from nucleus(GO:0010793) regulation of ribonucleoprotein complex localization(GO:2000197) |
| 0.7 |
0.7 |
GO:0034140 |
negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) |
| 0.7 |
5.9 |
GO:0006183 |
GTP biosynthetic process(GO:0006183) |
| 0.7 |
2.6 |
GO:0008635 |
activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
| 0.7 |
3.9 |
GO:0061299 |
retina vasculature morphogenesis in camera-type eye(GO:0061299) |
| 0.7 |
11.8 |
GO:0043524 |
negative regulation of neuron apoptotic process(GO:0043524) |
| 0.7 |
2.6 |
GO:1904008 |
response to monosodium glutamate(GO:1904008) cellular response to monosodium glutamate(GO:1904009) |
| 0.6 |
5.8 |
GO:0071763 |
nuclear membrane organization(GO:0071763) |
| 0.6 |
9.7 |
GO:1904816 |
positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
| 0.6 |
12.9 |
GO:0071470 |
cellular response to osmotic stress(GO:0071470) |
| 0.6 |
1.9 |
GO:2000383 |
regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
| 0.6 |
10.9 |
GO:0048026 |
positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
| 0.6 |
3.2 |
GO:0044829 |
positive regulation by host of viral genome replication(GO:0044829) |
| 0.6 |
10.8 |
GO:0072698 |
protein localization to microtubule cytoskeleton(GO:0072698) |
| 0.6 |
1.9 |
GO:0036092 |
phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
| 0.6 |
1.9 |
GO:0048312 |
intracellular distribution of mitochondria(GO:0048312) |
| 0.6 |
1.2 |
GO:0039530 |
MDA-5 signaling pathway(GO:0039530) |
| 0.6 |
3.1 |
GO:0070166 |
enamel mineralization(GO:0070166) |
| 0.6 |
1.8 |
GO:0010520 |
regulation of reciprocal meiotic recombination(GO:0010520) positive regulation of reciprocal meiotic recombination(GO:0010845) |
| 0.6 |
4.2 |
GO:0060068 |
vagina development(GO:0060068) |
| 0.6 |
5.3 |
GO:0070389 |
chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.6 |
3.5 |
GO:0033689 |
negative regulation of osteoblast proliferation(GO:0033689) |
| 0.6 |
2.9 |
GO:1902775 |
mitochondrial large ribosomal subunit assembly(GO:1902775) |
| 0.6 |
4.7 |
GO:0031935 |
regulation of chromatin silencing(GO:0031935) |
| 0.6 |
3.5 |
GO:0097151 |
positive regulation of inhibitory postsynaptic potential(GO:0097151) |
| 0.6 |
2.9 |
GO:0070535 |
histone H2A K63-linked ubiquitination(GO:0070535) |
| 0.6 |
2.9 |
GO:0010273 |
detoxification of copper ion(GO:0010273) detoxification of inorganic compound(GO:0061687) stress response to copper ion(GO:1990169) |
| 0.6 |
24.2 |
GO:1902850 |
mitotic spindle assembly(GO:0090307) microtubule cytoskeleton organization involved in mitosis(GO:1902850) |
| 0.6 |
1.1 |
GO:1902255 |
positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
| 0.6 |
1.7 |
GO:1903204 |
negative regulation of oxidative stress-induced neuron death(GO:1903204) |
| 0.6 |
1.7 |
GO:0034139 |
regulation of toll-like receptor 3 signaling pathway(GO:0034139) |
| 0.6 |
5.6 |
GO:0000729 |
DNA double-strand break processing(GO:0000729) |
| 0.6 |
3.9 |
GO:0061000 |
negative regulation of dendritic spine development(GO:0061000) |
| 0.5 |
2.2 |
GO:0071732 |
cellular response to nitric oxide(GO:0071732) |
| 0.5 |
6.0 |
GO:0090435 |
protein localization to nuclear envelope(GO:0090435) |
| 0.5 |
4.9 |
GO:0043518 |
negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
| 0.5 |
3.2 |
GO:0098789 |
pre-mRNA cleavage required for polyadenylation(GO:0098789) |
| 0.5 |
10.8 |
GO:0097150 |
neuronal stem cell population maintenance(GO:0097150) |
| 0.5 |
13.3 |
GO:0000413 |
protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.5 |
2.6 |
GO:0060059 |
embryonic retina morphogenesis in camera-type eye(GO:0060059) |
| 0.5 |
2.1 |
GO:1900016 |
negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
| 0.5 |
5.2 |
GO:0035520 |
monoubiquitinated protein deubiquitination(GO:0035520) |
| 0.5 |
7.7 |
GO:0007519 |
skeletal muscle tissue development(GO:0007519) |
| 0.5 |
1.5 |
GO:0000389 |
generation of catalytic spliceosome for second transesterification step(GO:0000350) mRNA 3'-splice site recognition(GO:0000389) |
| 0.5 |
17.9 |
GO:0007032 |
endosome organization(GO:0007032) |
| 0.5 |
1.5 |
GO:0043987 |
histone-serine phosphorylation(GO:0035404) histone H3-S10 phosphorylation(GO:0043987) |
| 0.5 |
5.4 |
GO:0061179 |
negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.5 |
7.4 |
GO:0045722 |
positive regulation of gluconeogenesis(GO:0045722) |
| 0.5 |
3.9 |
GO:0048386 |
positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.5 |
2.0 |
GO:0051572 |
negative regulation of histone H3-K4 methylation(GO:0051572) |
| 0.5 |
7.2 |
GO:0006825 |
copper ion transport(GO:0006825) |
| 0.5 |
4.3 |
GO:0006517 |
protein deglycosylation(GO:0006517) |
| 0.5 |
2.4 |
GO:0097503 |
sialylation(GO:0097503) |
| 0.5 |
0.9 |
GO:0009146 |
purine nucleoside triphosphate catabolic process(GO:0009146) |
| 0.5 |
7.4 |
GO:0050434 |
positive regulation of viral transcription(GO:0050434) |
| 0.5 |
1.4 |
GO:1902416 |
positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
| 0.5 |
1.4 |
GO:0001828 |
inner cell mass cell fate commitment(GO:0001827) inner cell mass cellular morphogenesis(GO:0001828) |
| 0.5 |
1.8 |
GO:0034379 |
very-low-density lipoprotein particle assembly(GO:0034379) |
| 0.5 |
2.3 |
GO:0042117 |
monocyte activation(GO:0042117) |
| 0.5 |
1.4 |
GO:0006546 |
glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 0.5 |
15.4 |
GO:0006378 |
mRNA polyadenylation(GO:0006378) |
| 0.5 |
6.3 |
GO:0051123 |
RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
| 0.5 |
1.4 |
GO:0042264 |
peptidyl-aspartic acid hydroxylation(GO:0042264) negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
| 0.4 |
1.8 |
GO:2000049 |
positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
| 0.4 |
12.1 |
GO:0046677 |
response to antibiotic(GO:0046677) |
| 0.4 |
1.8 |
GO:0051643 |
endoplasmic reticulum localization(GO:0051643) |
| 0.4 |
6.7 |
GO:0060216 |
definitive hemopoiesis(GO:0060216) |
| 0.4 |
3.6 |
GO:0010587 |
miRNA catabolic process(GO:0010587) |
| 0.4 |
4.3 |
GO:0050684 |
regulation of mRNA processing(GO:0050684) |
| 0.4 |
79.0 |
GO:0006260 |
DNA replication(GO:0006260) |
| 0.4 |
6.3 |
GO:0097062 |
dendritic spine maintenance(GO:0097062) |
| 0.4 |
4.2 |
GO:0090557 |
establishment of endothelial intestinal barrier(GO:0090557) |
| 0.4 |
1.2 |
GO:1902626 |
assembly of large subunit precursor of preribosome(GO:1902626) |
| 0.4 |
2.9 |
GO:0005981 |
regulation of glycogen catabolic process(GO:0005981) |
| 0.4 |
4.9 |
GO:0006654 |
phosphatidic acid biosynthetic process(GO:0006654) phosphatidic acid metabolic process(GO:0046473) |
| 0.4 |
6.0 |
GO:0044342 |
type B pancreatic cell proliferation(GO:0044342) |
| 0.4 |
17.5 |
GO:0010501 |
RNA secondary structure unwinding(GO:0010501) |
| 0.4 |
6.7 |
GO:0045070 |
positive regulation of viral genome replication(GO:0045070) |
| 0.4 |
2.7 |
GO:0006309 |
apoptotic DNA fragmentation(GO:0006309) |
| 0.4 |
2.6 |
GO:1904262 |
negative regulation of TORC1 signaling(GO:1904262) |
| 0.4 |
1.8 |
GO:0046501 |
protoporphyrinogen IX metabolic process(GO:0046501) |
| 0.4 |
10.6 |
GO:0000725 |
double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
| 0.4 |
0.7 |
GO:0035989 |
tendon development(GO:0035989) |
| 0.4 |
1.8 |
GO:0045053 |
protein retention in Golgi apparatus(GO:0045053) |
| 0.4 |
6.2 |
GO:0006907 |
pinocytosis(GO:0006907) |
| 0.4 |
1.4 |
GO:0097527 |
necroptotic signaling pathway(GO:0097527) |
| 0.4 |
1.1 |
GO:0050667 |
homocysteine metabolic process(GO:0050667) |
| 0.4 |
5.6 |
GO:1900027 |
regulation of ruffle assembly(GO:1900027) |
| 0.3 |
2.4 |
GO:0000460 |
maturation of 5.8S rRNA(GO:0000460) |
| 0.3 |
1.0 |
GO:0071550 |
death-inducing signaling complex assembly(GO:0071550) |
| 0.3 |
3.9 |
GO:0031125 |
rRNA 3'-end processing(GO:0031125) |
| 0.3 |
0.6 |
GO:0045041 |
protein import into mitochondrial intermembrane space(GO:0045041) |
| 0.3 |
1.6 |
GO:0071894 |
histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 0.3 |
1.6 |
GO:0030539 |
male genitalia development(GO:0030539) |
| 0.3 |
3.8 |
GO:0006607 |
NLS-bearing protein import into nucleus(GO:0006607) |
| 0.3 |
0.9 |
GO:0070365 |
hepatocyte differentiation(GO:0070365) |
| 0.3 |
3.7 |
GO:0034389 |
lipid particle organization(GO:0034389) |
| 0.3 |
9.0 |
GO:0043550 |
regulation of lipid kinase activity(GO:0043550) |
| 0.3 |
6.5 |
GO:0006359 |
regulation of transcription from RNA polymerase III promoter(GO:0006359) |
| 0.3 |
3.4 |
GO:0010172 |
embryonic body morphogenesis(GO:0010172) |
| 0.3 |
2.7 |
GO:0045292 |
mRNA cis splicing, via spliceosome(GO:0045292) |
| 0.3 |
21.3 |
GO:0045727 |
positive regulation of translation(GO:0045727) |
| 0.3 |
3.3 |
GO:0007130 |
synaptonemal complex assembly(GO:0007130) |
| 0.3 |
1.2 |
GO:0036151 |
platelet activating factor biosynthetic process(GO:0006663) phosphatidylcholine acyl-chain remodeling(GO:0036151) platelet activating factor metabolic process(GO:0046469) |
| 0.3 |
2.0 |
GO:1903301 |
positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
| 0.3 |
0.9 |
GO:0021764 |
amygdala development(GO:0021764) |
| 0.3 |
0.6 |
GO:0034384 |
positive regulation of lipoprotein particle clearance(GO:0010986) high-density lipoprotein particle clearance(GO:0034384) |
| 0.3 |
0.8 |
GO:0006434 |
seryl-tRNA aminoacylation(GO:0006434) |
| 0.3 |
2.8 |
GO:0007250 |
activation of NF-kappaB-inducing kinase activity(GO:0007250) |
| 0.3 |
0.6 |
GO:0019676 |
ammonia assimilation cycle(GO:0019676) |
| 0.3 |
1.4 |
GO:0045103 |
intermediate filament-based process(GO:0045103) |
| 0.3 |
4.7 |
GO:0042059 |
negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
| 0.3 |
3.8 |
GO:0043984 |
histone H4-K16 acetylation(GO:0043984) |
| 0.3 |
1.4 |
GO:0030277 |
maintenance of gastrointestinal epithelium(GO:0030277) |
| 0.3 |
1.9 |
GO:0048643 |
positive regulation of skeletal muscle tissue development(GO:0048643) |
| 0.3 |
5.4 |
GO:0051225 |
spindle assembly(GO:0051225) |
| 0.3 |
1.6 |
GO:1902035 |
positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
| 0.3 |
4.6 |
GO:1902043 |
positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
| 0.3 |
0.5 |
GO:0006295 |
nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
| 0.3 |
1.6 |
GO:0070933 |
histone H4 deacetylation(GO:0070933) |
| 0.3 |
0.8 |
GO:0006824 |
cobalt ion transport(GO:0006824) |
| 0.3 |
11.9 |
GO:0008584 |
male gonad development(GO:0008584) development of primary male sexual characteristics(GO:0046546) |
| 0.3 |
2.6 |
GO:0018065 |
protein-cofactor linkage(GO:0018065) |
| 0.3 |
7.4 |
GO:0007492 |
endoderm development(GO:0007492) |
| 0.3 |
5.6 |
GO:0006284 |
base-excision repair(GO:0006284) |
| 0.3 |
4.5 |
GO:0032755 |
positive regulation of interleukin-6 production(GO:0032755) |
| 0.2 |
24.5 |
GO:0043484 |
regulation of RNA splicing(GO:0043484) |
| 0.2 |
3.5 |
GO:0043248 |
proteasome assembly(GO:0043248) |
| 0.2 |
1.5 |
GO:0006390 |
transcription from mitochondrial promoter(GO:0006390) |
| 0.2 |
2.5 |
GO:0021796 |
cerebral cortex regionalization(GO:0021796) |
| 0.2 |
7.6 |
GO:0031122 |
cytoplasmic microtubule organization(GO:0031122) |
| 0.2 |
3.1 |
GO:0052646 |
alditol phosphate metabolic process(GO:0052646) |
| 0.2 |
1.8 |
GO:0043046 |
DNA methylation involved in gamete generation(GO:0043046) |
| 0.2 |
6.1 |
GO:0018345 |
protein palmitoylation(GO:0018345) |
| 0.2 |
1.6 |
GO:0002862 |
negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
| 0.2 |
4.0 |
GO:0006376 |
mRNA splice site selection(GO:0006376) |
| 0.2 |
1.8 |
GO:0010592 |
positive regulation of lamellipodium assembly(GO:0010592) |
| 0.2 |
8.1 |
GO:0035307 |
positive regulation of protein dephosphorylation(GO:0035307) |
| 0.2 |
0.9 |
GO:0032933 |
response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
| 0.2 |
0.9 |
GO:0036438 |
positive regulation of heterotypic cell-cell adhesion(GO:0034116) maintenance of lens transparency(GO:0036438) |
| 0.2 |
0.4 |
GO:0048262 |
determination of dorsal/ventral asymmetry(GO:0048262) determination of dorsal identity(GO:0048263) |
| 0.2 |
6.2 |
GO:0051028 |
mRNA transport(GO:0051028) |
| 0.2 |
0.9 |
GO:0032382 |
positive regulation of intracellular lipid transport(GO:0032379) positive regulation of intracellular sterol transport(GO:0032382) positive regulation of intracellular cholesterol transport(GO:0032385) regulation of cholesterol import(GO:0060620) lipid hydroperoxide transport(GO:1901373) positive regulation of cholesterol import(GO:1904109) regulation of sterol import(GO:2000909) positive regulation of sterol import(GO:2000911) |
| 0.2 |
4.9 |
GO:0033137 |
negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
| 0.2 |
0.4 |
GO:0034729 |
histone H3-K79 methylation(GO:0034729) |
| 0.2 |
3.9 |
GO:0031290 |
retinal ganglion cell axon guidance(GO:0031290) |
| 0.2 |
1.0 |
GO:0019236 |
response to pheromone(GO:0019236) |
| 0.2 |
1.0 |
GO:0048339 |
paraxial mesoderm development(GO:0048339) |
| 0.2 |
3.4 |
GO:0051654 |
establishment of mitochondrion localization(GO:0051654) |
| 0.2 |
4.8 |
GO:0060325 |
face morphogenesis(GO:0060325) |
| 0.2 |
1.6 |
GO:0021785 |
branchiomotor neuron axon guidance(GO:0021785) |
| 0.2 |
33.1 |
GO:0006281 |
DNA repair(GO:0006281) |
| 0.2 |
8.7 |
GO:0016126 |
sterol biosynthetic process(GO:0016126) |
| 0.2 |
0.9 |
GO:0030836 |
positive regulation of actin filament depolymerization(GO:0030836) |
| 0.2 |
1.4 |
GO:0035414 |
negative regulation of catenin import into nucleus(GO:0035414) |
| 0.2 |
1.4 |
GO:1990403 |
embryonic brain development(GO:1990403) |
| 0.2 |
2.8 |
GO:0042832 |
defense response to protozoan(GO:0042832) |
| 0.2 |
3.3 |
GO:0048247 |
lymphocyte chemotaxis(GO:0048247) |
| 0.2 |
2.2 |
GO:0010574 |
regulation of vascular endothelial growth factor production(GO:0010574) |
| 0.2 |
0.5 |
GO:0043247 |
protection from non-homologous end joining at telomere(GO:0031848) telomere maintenance in response to DNA damage(GO:0043247) |
| 0.2 |
1.0 |
GO:0003413 |
chondrocyte differentiation involved in endochondral bone morphogenesis(GO:0003413) |
| 0.2 |
5.8 |
GO:2000134 |
negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
| 0.2 |
1.5 |
GO:0043508 |
negative regulation of JUN kinase activity(GO:0043508) |
| 0.2 |
4.4 |
GO:0032728 |
positive regulation of interferon-beta production(GO:0032728) |
| 0.2 |
3.6 |
GO:0006783 |
heme biosynthetic process(GO:0006783) |
| 0.2 |
0.5 |
GO:0060347 |
heart trabecula formation(GO:0060347) |
| 0.2 |
4.7 |
GO:0007286 |
spermatid development(GO:0007286) |
| 0.2 |
6.4 |
GO:0016579 |
protein deubiquitination(GO:0016579) |
| 0.2 |
3.2 |
GO:0031146 |
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
| 0.2 |
38.8 |
GO:0007067 |
mitotic nuclear division(GO:0007067) |
| 0.2 |
1.6 |
GO:0045040 |
protein import into mitochondrial outer membrane(GO:0045040) |
| 0.2 |
0.3 |
GO:0034162 |
toll-like receptor 9 signaling pathway(GO:0034162) |
| 0.2 |
3.5 |
GO:0046676 |
negative regulation of insulin secretion(GO:0046676) |
| 0.2 |
0.8 |
GO:0048704 |
embryonic skeletal system morphogenesis(GO:0048704) |
| 0.1 |
0.7 |
GO:2000828 |
regulation of parathyroid hormone secretion(GO:2000828) |
| 0.1 |
0.1 |
GO:0090370 |
regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter(GO:0072368) negative regulation of cholesterol efflux(GO:0090370) |
| 0.1 |
2.7 |
GO:0021694 |
cerebellar Purkinje cell layer formation(GO:0021694) |
| 0.1 |
0.7 |
GO:0010025 |
wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
| 0.1 |
3.1 |
GO:0033539 |
fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.1 |
3.5 |
GO:0007369 |
gastrulation(GO:0007369) |
| 0.1 |
0.9 |
GO:2000300 |
regulation of synaptic vesicle exocytosis(GO:2000300) |
| 0.1 |
4.3 |
GO:0015914 |
phospholipid transport(GO:0015914) |
| 0.1 |
2.3 |
GO:0032784 |
regulation of DNA-templated transcription, elongation(GO:0032784) |
| 0.1 |
2.2 |
GO:0032781 |
positive regulation of ATPase activity(GO:0032781) |
| 0.1 |
1.5 |
GO:0061462 |
protein localization to lysosome(GO:0061462) |
| 0.1 |
4.3 |
GO:0007029 |
endoplasmic reticulum organization(GO:0007029) |
| 0.1 |
6.6 |
GO:0042273 |
ribosomal large subunit biogenesis(GO:0042273) |
| 0.1 |
0.3 |
GO:0086046 |
membrane depolarization during SA node cell action potential(GO:0086046) |
| 0.1 |
3.0 |
GO:0006367 |
transcription initiation from RNA polymerase II promoter(GO:0006367) |
| 0.1 |
0.3 |
GO:0070301 |
cellular response to hydrogen peroxide(GO:0070301) |
| 0.1 |
1.0 |
GO:0046039 |
GTP metabolic process(GO:0046039) |
| 0.1 |
4.0 |
GO:0060021 |
palate development(GO:0060021) |
| 0.1 |
0.4 |
GO:0039703 |
viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
| 0.1 |
2.9 |
GO:0006405 |
RNA export from nucleus(GO:0006405) |
| 0.1 |
0.3 |
GO:0006436 |
tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 0.1 |
6.7 |
GO:0007601 |
visual perception(GO:0007601) |
| 0.1 |
0.5 |
GO:1900452 |
regulation of long term synaptic depression(GO:1900452) |
| 0.1 |
0.1 |
GO:0035457 |
cellular response to interferon-alpha(GO:0035457) |
| 0.1 |
0.6 |
GO:0030826 |
positive regulation of cGMP metabolic process(GO:0030825) regulation of cGMP biosynthetic process(GO:0030826) positive regulation of cGMP biosynthetic process(GO:0030828) |
| 0.1 |
0.9 |
GO:0019368 |
fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.1 |
2.1 |
GO:0045600 |
positive regulation of fat cell differentiation(GO:0045600) |
| 0.1 |
0.8 |
GO:0034498 |
early endosome to Golgi transport(GO:0034498) |
| 0.1 |
0.7 |
GO:0043374 |
CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
| 0.1 |
0.4 |
GO:0051533 |
positive regulation of NFAT protein import into nucleus(GO:0051533) |
| 0.1 |
15.5 |
GO:0006397 |
mRNA processing(GO:0006397) |
| 0.1 |
0.2 |
GO:0021893 |
cerebral cortex GABAergic interneuron fate commitment(GO:0021893) |
| 0.1 |
2.6 |
GO:0007548 |
sex differentiation(GO:0007548) |
| 0.1 |
1.7 |
GO:0007498 |
mesoderm development(GO:0007498) |
| 0.1 |
0.6 |
GO:0006107 |
oxaloacetate metabolic process(GO:0006107) |
| 0.1 |
0.7 |
GO:0045667 |
regulation of osteoblast differentiation(GO:0045667) |
| 0.1 |
0.6 |
GO:0045647 |
negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.1 |
0.9 |
GO:0043252 |
sodium-independent organic anion transport(GO:0043252) |
| 0.1 |
4.6 |
GO:0051965 |
positive regulation of synapse assembly(GO:0051965) |
| 0.1 |
0.6 |
GO:0002052 |
positive regulation of neuroblast proliferation(GO:0002052) |
| 0.1 |
1.5 |
GO:0006911 |
phagocytosis, engulfment(GO:0006911) |
| 0.1 |
0.6 |
GO:0071392 |
cellular response to estradiol stimulus(GO:0071392) |
| 0.1 |
1.6 |
GO:0043627 |
response to estrogen(GO:0043627) |
| 0.0 |
0.3 |
GO:0051503 |
adenine nucleotide transport(GO:0051503) |
| 0.0 |
0.8 |
GO:0008299 |
isoprenoid biosynthetic process(GO:0008299) |
| 0.0 |
1.8 |
GO:1900046 |
regulation of blood coagulation(GO:0030193) regulation of hemostasis(GO:1900046) |
| 0.0 |
0.7 |
GO:0060716 |
labyrinthine layer blood vessel development(GO:0060716) |
| 0.0 |
0.7 |
GO:0030510 |
regulation of BMP signaling pathway(GO:0030510) |
| 0.0 |
4.8 |
GO:0008654 |
phospholipid biosynthetic process(GO:0008654) |
| 0.0 |
0.5 |
GO:1990126 |
retrograde transport, endosome to plasma membrane(GO:1990126) |
| 0.0 |
0.5 |
GO:0045071 |
negative regulation of viral genome replication(GO:0045071) |
| 0.0 |
0.4 |
GO:0097009 |
energy homeostasis(GO:0097009) |
| 0.0 |
1.0 |
GO:0000462 |
maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
| 0.0 |
0.8 |
GO:0043666 |
regulation of phosphoprotein phosphatase activity(GO:0043666) |
| 0.0 |
0.5 |
GO:0019915 |
lipid storage(GO:0019915) |
| 0.0 |
0.5 |
GO:0016574 |
histone ubiquitination(GO:0016574) |
| 0.0 |
0.5 |
GO:0045807 |
positive regulation of endocytosis(GO:0045807) |
| 0.0 |
0.3 |
GO:0051016 |
barbed-end actin filament capping(GO:0051016) |
| 0.0 |
0.5 |
GO:0007588 |
excretion(GO:0007588) |
| 0.0 |
0.5 |
GO:0048635 |
negative regulation of muscle organ development(GO:0048635) |
| 0.0 |
0.4 |
GO:0022617 |
extracellular matrix disassembly(GO:0022617) |
| 0.0 |
1.5 |
GO:0006413 |
translational initiation(GO:0006413) |
| 0.0 |
0.5 |
GO:0003009 |
skeletal muscle contraction(GO:0003009) |
| 0.0 |
0.4 |
GO:0006306 |
DNA alkylation(GO:0006305) DNA methylation(GO:0006306) DNA methylation or demethylation(GO:0044728) |
| 0.0 |
0.3 |
GO:0035329 |
hippo signaling(GO:0035329) |
| 0.0 |
0.4 |
GO:0001837 |
epithelial to mesenchymal transition(GO:0001837) |
| 0.0 |
0.9 |
GO:0006888 |
ER to Golgi vesicle-mediated transport(GO:0006888) |
| 0.0 |
0.4 |
GO:1901264 |
carbohydrate derivative transport(GO:1901264) |
| 0.0 |
0.4 |
GO:1902476 |
chloride transmembrane transport(GO:1902476) |
| 0.0 |
0.2 |
GO:0000154 |
rRNA modification(GO:0000154) |
| 0.0 |
0.5 |
GO:2001243 |
negative regulation of intrinsic apoptotic signaling pathway(GO:2001243) |
| 0.0 |
0.5 |
GO:0045454 |
cell redox homeostasis(GO:0045454) |
| 0.0 |
0.3 |
GO:0043966 |
histone H3 acetylation(GO:0043966) |
